Kyung-Soon Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kyung-Soon Park has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
Taek-Rim Yoon
25 shared publications- Taek-Rim Yoon
Department of Orthopedic Surgery, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Jeollanam-do, Republic of Korea
19 shared publications - Chan-Young Lee
Department of Orthopedic Surgery, Center for Joint Disease, Chonnam National University Medical School and Hospital, Hwasun-gun 58128, Republic of Korea
8 shared publications Chan Young Lee
7 shared publications- Chan Young Lee
Department of Orthopedic Surgery, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Jeollanam-do, Republic of Korea
7 shared publications - Le Wan
Department of Orthopedic Surgery, Center for Joint Disease, Chonnam National University Medical School and Hospital, Hwasun-gun 58128, Republic of Korea
7 shared publications
Latest Publications
- 29 July 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
Cup-Cage Reconstruction for Massive Acetabular Defects: A Proven Solution for the Most Challenging Acetabular Revisions?
Was not provided for this article.
- 29 July 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
Cup-Cage Reconstruction for Massive Acetabular Defects: A Proven Solution for the Most Challenging Acetabular Revisions?
Was not provided for this article.
- Open Access
Periprosthetic Joint Infection: Biofilm Pathogenesis, Immune Dysregulation, and Emerging Prosthetic Interface Strategies
Periprosthetic joint infection (PJI) remains a major clinical challenge after total joint arthroplasty because of its association with prolonged antimicrobial therapy, repeated surgery, implant failure, functional disability, and substantial socioeconomic burden. Current strategies, including systemic antibiotics, debridement with implant retention, staged revision, and antibiotic-loaded cement spacers, remain indispensable but are limited by mature biofilm tolerance, protected microbial reservoirs, insufficient local drug penetration, persistent inflammation, and compromised periprosthetic bone repair. Increasing evidence indicates that PJI is not merely bacterial colonization of an implant surface, but a dynamic prosthetic interface disorder involving biofilm persistence, immune dysregulation, inflammatory osteolysis, and failed osseointegration. This review summarizes recent advances in anti-infective prosthetic interface design, emphasizing the transition from passive antibacterial coatings toward multifunctional immuno-antibacterial osseointegrative systems. The pathogenic basis of PJI is first discussed, including conditioning film formation, bacterial adhesion, biofilm maturation, protected reservoirs, immune evasion, and osteolysis. Current clinical management limitations are then evaluated, followed by emerging biomaterial strategies, including anti-adhesive and contact-killing surfaces, active antimicrobial coatings, mature biofilm disruption, biological antibiofilm therapies, smart infection-responsive delivery systems, and osteoimmunomodulatory interfaces. Particular attention is given to balancing early antibacterial activity with cytocompatibility, immune resolution, angiogenesis, mechanical durability, and long-term osseointegration. Finally, key translational barriers are highlighted, including load-bearing and tribological constraints, insufficiently standardized mature biofilm and animal models, limited clinical evidence for advanced smart materials, manufacturing reproducibility, sterilization compatibility, regulatory complexity, and application-specific clinical readiness. Future anti-PJI interfaces should evolve beyond unidirectional bacterial killing toward stage-specific systems integrating biofilm control, immune restoration, vascularized bone regeneration, and durable mechanical performance.
Open AccessPeriprosthetic Joint Infection: Biofilm Pathogenesis, Immune Dysregulation, and Emerging Prosthetic Interface Strategies
Periprosthetic joint infection (PJI) remains a major clinical challenge after total joint arthroplasty because of its association with prolonged antimicrobial therapy, repeated surgery, implant failure, functional disability, and substantial socioeconomic burden. Current strategies, including systemic antibiotics, debridement with implant retention, staged revision, and antibiotic-loaded cement spacers, remain indispensable but are limited by mature biofilm tolerance, protected microbial reservoirs, insufficient local drug penetration, persistent inflammation, and compromised periprosthetic bone repair. Increasing evidence indicates that PJI is not merely bacterial colonization of an implant surface, but a dynamic prosthetic interface disorder involving biofilm persistence, immune dysregulation, inflammatory osteolysis, and failed osseointegration. This review summarizes recent advances in anti-infective prosthetic interface design, emphasizing the transition from passive antibacterial coatings toward multifunctional immuno-antibacterial osseointegrative systems. The pathogenic basis of PJI is first discussed, including conditioning film formation, bacterial adhesion, biofilm maturation, protected reservoirs, immune evasion, and osteolysis. Current clinical management limitations are then evaluated, followed by emerging biomaterial strategies, including anti-adhesive and contact-killing surfaces, active antimicrobial coatings, mature biofilm disruption, biological antibiofilm therapies, smart infection-responsive delivery systems, and osteoimmunomodulatory interfaces. Particular attention is given to balancing early antibacterial activity with cytocompatibility, immune resolution, angiogenesis, mechanical durability, and long-term osseointegration. Finally, key translational barriers are highlighted, including load-bearing and tribological constraints, insufficiently standardized mature biofilm and animal models, limited clinical evidence for advanced smart materials, manufacturing reproducibility, sterilization compatibility, regulatory complexity, and application-specific clinical readiness. Future anti-PJI interfaces should evolve beyond unidirectional bacterial killing toward stage-specific systems integrating biofilm control, immune restoration, vascularized bone regeneration, and durable mechanical performance.
- Open Access
- 1 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 574
Stage-Dependent Antibiofilm Effects of UVA Combined with Cinnamaldehyde Against Staphylococcus aureus Biofilms on Titanium Surfaces
Staphylococcus aureus biofilms formed on titanium surfaces are highly relevant to orthopedic implant-associated infection and remain difficult to control after maturation. This study aimed to evaluate whether ultraviolet A (UVA, 365 nm) combined with cinnamaldehyde (CA) could improve antibiofilm activity against titanium-associated S. aureus biofilms in a stage-resolved in vitro model and to examine whether the observed responses were associated with reactive oxygen species (ROS). Early stage (8 h) and 24 h biofilm models were established on total hip arthroplasty (THA)-derived titanium discs. After condition screening, 0.5 mM CA combined with 5 min UVA exposure was selected for subsequent experiments. Biofilm biomass was assessed by crystal violet staining, bacterial viability by live/dead staining and colony-forming unit (CFU) enumeration, ROS-associated fluorescence by dihydroethidium (DHE) imaging, and biofilm-associated gene expression by quantitative real-time PCR (qRT-PCR). Chondrocyte viability was also evaluated under the selected antibiofilm-effective conditions. The combined treatment showed stage-dependent antibiofilm effects, with greater biomass reduction in the 8 h biofilm model and marked impairment of bacterial viability and culturability in both models. ROS-associated fluorescence increased under combined exposure and was partially attenuated by N-acetyl-L-cysteine (NAC) in the 24 h biofilm model. In parallel, CA + UVA was associated with lower expression levels of clfA, icaA, and icaD in the 8 h biofilm model and of icaA, icaB, and icaD in the 24 h biofilm model, with partial NAC attenuation in the latter. Chondrocyte viability was lower in all treatment groups than in the untreated control, although the combined treatment did not show an obvious additional decrease compared with the single-treatment groups. These findings indicate that UVA combined with CA exerts stage-dependent antibiofilm effects in an in vitro titanium-associated S. aureus biofilm model. The observed ROS-associated responses were consistent with, but do not establish, mechanistic involvement. The current treatment setting also requires further optimization before translational applicability can be more confidently considered.
- 1 May 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (5) , 574
Open AccessStage-Dependent Antibiofilm Effects of UVA Combined with Cinnamaldehyde Against Staphylococcus aureus Biofilms on Titanium Surfaces
Staphylococcus aureus biofilms formed on titanium surfaces are highly relevant to orthopedic implant-associated infection and remain difficult to control after maturation. This study aimed to evaluate whether ultraviolet A (UVA, 365 nm) combined with cinnamaldehyde (CA) could improve antibiofilm activity against titanium-associated S. aureus biofilms in a stage-resolved in vitro model and to examine whether the observed responses were associated with reactive oxygen species (ROS). Early stage (8 h) and 24 h biofilm models were established on total hip arthroplasty (THA)-derived titanium discs. After condition screening, 0.5 mM CA combined with 5 min UVA exposure was selected for subsequent experiments. Biofilm biomass was assessed by crystal violet staining, bacterial viability by live/dead staining and colony-forming unit (CFU) enumeration, ROS-associated fluorescence by dihydroethidium (DHE) imaging, and biofilm-associated gene expression by quantitative real-time PCR (qRT-PCR). Chondrocyte viability was also evaluated under the selected antibiofilm-effective conditions. The combined treatment showed stage-dependent antibiofilm effects, with greater biomass reduction in the 8 h biofilm model and marked impairment of bacterial viability and culturability in both models. ROS-associated fluorescence increased under combined exposure and was partially attenuated by N-acetyl-L-cysteine (NAC) in the 24 h biofilm model. In parallel, CA + UVA was associated with lower expression levels of clfA, icaA, and icaD in the 8 h biofilm model and of icaA, icaB, and icaD in the 24 h biofilm model, with partial NAC attenuation in the latter. Chondrocyte viability was lower in all treatment groups than in the untreated control, although the combined treatment did not show an obvious additional decrease compared with the single-treatment groups. These findings indicate that UVA combined with CA exerts stage-dependent antibiofilm effects in an in vitro titanium-associated S. aureus biofilm model. The observed ROS-associated responses were consistent with, but do not establish, mechanistic involvement. The current treatment setting also requires further optimization before translational applicability can be more confidently considered.
- Open Access
- 18 March 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 357
A Systematic Review on Amnion as a Cell Delivery Scaffolding Material for Cartilage Regeneration in Pre-Clinical and Clinical Studies
Cartilage is an important yet vulnerable tissue with limited self-healing capacity, where damage often progresses to joint degeneration, which eventually leads to severe osteoarthritis (OA). Current tissue engineering strategies focus on biocompatible scaffolds for cartilage regeneration, particularly amnion (or amniotic membrane), emerging as a promising biomaterial due to its wide availability, low immunogenicity, and naturally derived microenvironment that is advantageous for cartilage regeneration. This systematic review aims to evaluate the existing evidence on the efficacy of amnion as a tissue scaffolding material for cartilage regeneration in both preclinical and clinical studies. Using terms such as “cartilage damage”, “cartilage injuries”, “amnion” and “amniotic membrane”, 19 relevant studies were identified across three major databases (PubMed, Scopus and Web of Science) until 25 December 2025. All preclinical and clinical studies that utilized amnion for cartilage repair or as cartilage tissue engineering scaffolding materials were included. Evidence quality was assessed using the OHAT and MINORS risk of bias tool. This study is prospectively registered in the PROSPERO database under the ID 1178444. The findings consistently indicate that amniotic scaffolds, regardless of processing methods or cell seeding, yield favorable outcomes without adverse effects across different species. In vitro analysis revealed that treatment groups with amnion show better cell attachment, viability, and proliferation, and higher content of cartilage-related markers expressed by the seeded cells, either chondrocyte, bone marrow-derived mesenchymal stem cells (MSCs), adipose tissue-derived MSCs, placenta-derived MSCs, umbilical cord-derived MSCs, amniotic MSCs or amniotic epithelial cells. In in vivo and ex vivo studies, amnion-treated groups demonstrated improved quality of the treated cartilage, with better integration, as indicated by higher histological scores and the presence of type II collagen (COL-II). There was an inconsistency in the reporting of cartilage defect dimensions in the in vivo models across the different studies. Nevertheless, the outcome measurements were consistently reported with histological analysis, with or without International Cartilage Repair Society (ICRS) scoring and immunohistochemistry (IHC) analysis, across the studies. Clinically, most subjects show improvement in the Knee Injury and Osteoarthritis Outcome Score (KOOS) Sports and Recreation score and KOOS Quality of Life score, as well as reduced Visual Analogue Scale (VAS) average and maximum pain scores. In conclusion, preclinical and clinical studies support amnion as an ideal scaffold material for cartilage tissue engineering and regeneration. Future research should focus on optimizing and standardizing amnion scaffold preparation at a production scale to facilitate the translation of these positive outcomes into clinical applications. This study is funded by the Ministry of Higher Education Malaysia via Prototype Research Grant Scheme (PRGS/1/2021/SKK01/UM/02/1) and UM International Collaboration Grant—2023 SATU Joint Research Scheme Program: ST007-2024.
- 18 March 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 357
Open AccessA Systematic Review on Amnion as a Cell Delivery Scaffolding Material for Cartilage Regeneration in Pre-Clinical and Clinical Studies
Cartilage is an important yet vulnerable tissue with limited self-healing capacity, where damage often progresses to joint degeneration, which eventually leads to severe osteoarthritis (OA). Current tissue engineering strategies focus on biocompatible scaffolds for cartilage regeneration, particularly amnion (or amniotic membrane), emerging as a promising biomaterial due to its wide availability, low immunogenicity, and naturally derived microenvironment that is advantageous for cartilage regeneration. This systematic review aims to evaluate the existing evidence on the efficacy of amnion as a tissue scaffolding material for cartilage regeneration in both preclinical and clinical studies. Using terms such as “cartilage damage”, “cartilage injuries”, “amnion” and “amniotic membrane”, 19 relevant studies were identified across three major databases (PubMed, Scopus and Web of Science) until 25 December 2025. All preclinical and clinical studies that utilized amnion for cartilage repair or as cartilage tissue engineering scaffolding materials were included. Evidence quality was assessed using the OHAT and MINORS risk of bias tool. This study is prospectively registered in the PROSPERO database under the ID 1178444. The findings consistently indicate that amniotic scaffolds, regardless of processing methods or cell seeding, yield favorable outcomes without adverse effects across different species. In vitro analysis revealed that treatment groups with amnion show better cell attachment, viability, and proliferation, and higher content of cartilage-related markers expressed by the seeded cells, either chondrocyte, bone marrow-derived mesenchymal stem cells (MSCs), adipose tissue-derived MSCs, placenta-derived MSCs, umbilical cord-derived MSCs, amniotic MSCs or amniotic epithelial cells. In in vivo and ex vivo studies, amnion-treated groups demonstrated improved quality of the treated cartilage, with better integration, as indicated by higher histological scores and the presence of type II collagen (COL-II). There was an inconsistency in the reporting of cartilage defect dimensions in the in vivo models across the different studies. Nevertheless, the outcome measurements were consistently reported with histological analysis, with or without International Cartilage Repair Society (ICRS) scoring and immunohistochemistry (IHC) analysis, across the studies. Clinically, most subjects show improvement in the Knee Injury and Osteoarthritis Outcome Score (KOOS) Sports and Recreation score and KOOS Quality of Life score, as well as reduced Visual Analogue Scale (VAS) average and maximum pain scores. In conclusion, preclinical and clinical studies support amnion as an ideal scaffold material for cartilage tissue engineering and regeneration. Future research should focus on optimizing and standardizing amnion scaffold preparation at a production scale to facilitate the translation of these positive outcomes into clinical applications. This study is funded by the Ministry of Higher Education Malaysia via Prototype Research Grant Scheme (PRGS/1/2021/SKK01/UM/02/1) and UM International Collaboration Grant—2023 SATU Joint Research Scheme Program: ST007-2024.
- Open Access
- 23 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1672
Mid-Term Results of Ceramic Monoblock Acetabular Cups in Primary Total Hip Arthroplasty: A Minimum 5-Year Follow-Up
Introduction: Ceramic-on-ceramic (CoC) articulation in total hip arthroplasty (THA) offers excellent wear characteristics but carries risks such as liner malseating and ceramic fracture. To solve these problems, monoblock acetabular cups with preassembled ceramic liners were developed to minimize technical errors and allow the use of larger femoral heads. This study aimed to evaluate the mid-term clinical and radiological outcomes of a ceramic monoblock acetabular cup system. Methods: A retrospective analysis was performed on 106 primary THAs in South Korean patients using the Maxera monoblock cup (Zimmer Biomet) between 2015 and 2018, with a minimum follow-up of 5 years. Clinical outcomes were assessed using the Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Visual Analog Scale (VAS). Radiologic evaluation included osteolysis and radiolucent lines. Normality of clinical variables was confirmed, and pre-to-postoperative comparisons were performed using paired t-tests. Results: The mean follow-up was 6.8 ± 1.4 years. The most common preoperative diagnosis was avascular necrosis (66.0%). Cups sized ≤52 mm were used in 80.2% of hips, allowing the frequent use of large femoral heads (32–40 mm). Clinical scores improved significantly: HHS from 37.0 ± 13.4 to 90.8 ± 6.2, WOMAC from 66.6 ± 11.5 to 7.6 ± 6.7, and VAS from 6.45 ± 1.1 to 1.1 ± 0.8 (p < 0.001). No osteolysis was observed. Radiolucent lines was appeared in four hips (3.7%) without evidence of migration or loosening. One cup fixation failure (0.9%) required revision. No cases of ceramic fracture, squeaking, or dislocation occurred. Conclusions: The ceramic monoblock acetabular cup demonstrated excellent mid-term clinical and radiological outcomes with a very low complication rate. The ability to reliably use large femoral heads likely contributed to enhanced joint stability. However, the absence of screw fixation and inability to directly visualize cup insertion require careful attention during cup impaction. Long-term studies with comparative cohorts are warranted.
- 23 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1672
Open AccessMid-Term Results of Ceramic Monoblock Acetabular Cups in Primary Total Hip Arthroplasty: A Minimum 5-Year Follow-Up
Introduction: Ceramic-on-ceramic (CoC) articulation in total hip arthroplasty (THA) offers excellent wear characteristics but carries risks such as liner malseating and ceramic fracture. To solve these problems, monoblock acetabular cups with preassembled ceramic liners were developed to minimize technical errors and allow the use of larger femoral heads. This study aimed to evaluate the mid-term clinical and radiological outcomes of a ceramic monoblock acetabular cup system. Methods: A retrospective analysis was performed on 106 primary THAs in South Korean patients using the Maxera monoblock cup (Zimmer Biomet) between 2015 and 2018, with a minimum follow-up of 5 years. Clinical outcomes were assessed using the Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Visual Analog Scale (VAS). Radiologic evaluation included osteolysis and radiolucent lines. Normality of clinical variables was confirmed, and pre-to-postoperative comparisons were performed using paired t-tests. Results: The mean follow-up was 6.8 ± 1.4 years. The most common preoperative diagnosis was avascular necrosis (66.0%). Cups sized ≤52 mm were used in 80.2% of hips, allowing the frequent use of large femoral heads (32–40 mm). Clinical scores improved significantly: HHS from 37.0 ± 13.4 to 90.8 ± 6.2, WOMAC from 66.6 ± 11.5 to 7.6 ± 6.7, and VAS from 6.45 ± 1.1 to 1.1 ± 0.8 (p < 0.001). No osteolysis was observed. Radiolucent lines was appeared in four hips (3.7%) without evidence of migration or loosening. One cup fixation failure (0.9%) required revision. No cases of ceramic fracture, squeaking, or dislocation occurred. Conclusions: The ceramic monoblock acetabular cup demonstrated excellent mid-term clinical and radiological outcomes with a very low complication rate. The ability to reliably use large femoral heads likely contributed to enhanced joint stability. However, the absence of screw fixation and inability to directly visualize cup insertion require careful attention during cup impaction. Long-term studies with comparative cohorts are warranted.
- Open Access
- 6 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 405
MAKO Robotic-Arm-Assisted Versus Conventional Dual-Incision Total Hip Arthroplasty: A Propensity-Score-Matched Retrospective Study
Background: This propensity-score-matched retrospective study compared radiographic accuracy and short-term functional outcomes between MAKO robotic-arm-assisted and conventional dual-incision minimally invasive total hip arthroplasty (THA). It was hypothesized that robotic assistance would provide superior radiographic accuracy, primarily smaller absolute deviations from the planned acetabular inclination and anteversion and a higher proportion of cups within the Lewinnek safe zone, without improving early functional outcomes. Methods: Consecutive patients who underwent dual-incision total hip arthroplasty were retrospectively analyzed at two affiliated institutions between March 2023 and March 2025. The study included 52 robotic-arm-assisted cases. The dual-incision technique used an anterolateral incision for acetabular preparation and cup implantation and a posterolateral incision for femoral preparation and stem implantation. Propensity score matching (1:1) generated 52 balanced pairs for age, sex, body mass index (BMI), preoperative Harris Hip Score (HHS), ASA class, and diagnosis. Operative time, blood loss, radiographic accuracy (acetabular anteversion, inclination, leg-length discrepancy [LLD], femoral and combined offsets, and stem subsidence), and functional outcomes (HHS, Oxford Hip Score [OHS], Forgotten Joint Score-12 [FJS-12]) were compared. Results: The robotic group achieved smaller deviations from the planned anteversion (1.15° vs. 3.0°, p < 0.001) and inclination (1.33° vs. 4.5°, p < 0.001), with a higher proportion of cups within the Lewinnek safe zone (98.1% vs. 82.7%, p = 0.016). Significant improvements were also seen in femoral stem subsidence (p = 0.006) and offset restoration, although the reduction in leg-length discrepancy did not reach statistical significance. Operative time was longer (77.8 vs. 65.0 min, p = 0.001), while blood loss and 6-month functional scores were comparable (HHS, p = 0.144; OHS, p = 0.328). Multivariable regression confirmed that greater deviations in acetabular orientation, higher LLD, and increased subsidence were independent predictors of poorer functional outcomes. Conclusions: MAKO robotic-arm assistance was associated with improved radiographic accuracy and biomechanical restoration in dual-incision THA, but no direct short-term functional advantage was observed. Greater radiographic precision was independently associated with better patient-reported outcomes, suggesting that technical precision is a key factor in optimizing early postoperative outcomes, highlighting the importance of technical accuracy in total hip arthroplasty.
- 6 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 405
Open AccessMAKO Robotic-Arm-Assisted Versus Conventional Dual-Incision Total Hip Arthroplasty: A Propensity-Score-Matched Retrospective Study
Background: This propensity-score-matched retrospective study compared radiographic accuracy and short-term functional outcomes between MAKO robotic-arm-assisted and conventional dual-incision minimally invasive total hip arthroplasty (THA). It was hypothesized that robotic assistance would provide superior radiographic accuracy, primarily smaller absolute deviations from the planned acetabular inclination and anteversion and a higher proportion of cups within the Lewinnek safe zone, without improving early functional outcomes. Methods: Consecutive patients who underwent dual-incision total hip arthroplasty were retrospectively analyzed at two affiliated institutions between March 2023 and March 2025. The study included 52 robotic-arm-assisted cases. The dual-incision technique used an anterolateral incision for acetabular preparation and cup implantation and a posterolateral incision for femoral preparation and stem implantation. Propensity score matching (1:1) generated 52 balanced pairs for age, sex, body mass index (BMI), preoperative Harris Hip Score (HHS), ASA class, and diagnosis. Operative time, blood loss, radiographic accuracy (acetabular anteversion, inclination, leg-length discrepancy [LLD], femoral and combined offsets, and stem subsidence), and functional outcomes (HHS, Oxford Hip Score [OHS], Forgotten Joint Score-12 [FJS-12]) were compared. Results: The robotic group achieved smaller deviations from the planned anteversion (1.15° vs. 3.0°, p < 0.001) and inclination (1.33° vs. 4.5°, p < 0.001), with a higher proportion of cups within the Lewinnek safe zone (98.1% vs. 82.7%, p = 0.016). Significant improvements were also seen in femoral stem subsidence (p = 0.006) and offset restoration, although the reduction in leg-length discrepancy did not reach statistical significance. Operative time was longer (77.8 vs. 65.0 min, p = 0.001), while blood loss and 6-month functional scores were comparable (HHS, p = 0.144; OHS, p = 0.328). Multivariable regression confirmed that greater deviations in acetabular orientation, higher LLD, and increased subsidence were independent predictors of poorer functional outcomes. Conclusions: MAKO robotic-arm assistance was associated with improved radiographic accuracy and biomechanical restoration in dual-incision THA, but no direct short-term functional advantage was observed. Greater radiographic precision was independently associated with better patient-reported outcomes, suggesting that technical precision is a key factor in optimizing early postoperative outcomes, highlighting the importance of technical accuracy in total hip arthroplasty.
- Open Access
- 1 January 2026
- Published by XMLink in Clinics in Orthopedic Surgery
- Vol. 18 (5) , 813-820
Increased Accuracy of Acetabular Cup Positioning with an Automatic Impaction Device in Total Hip Arthroplasty
Song H, et al. Clin Orthop Surg. 2026 Oct;18(5):813-820. https://doi.org/10.4055/cios26102
- 1 January 2026
- Published by XMLink in Clinics in Orthopedic Surgery
- Vol. 18 (5) , 813-820
Open AccessIncreased Accuracy of Acetabular Cup Positioning with an Automatic Impaction Device in Total Hip Arthroplasty
Song H, et al. Clin Orthop Surg. 2026 Oct;18(5):813-820. https://doi.org/10.4055/cios26102